Facial Injectables Market Size & Share, by Product (Collagen, Hyaluronic Acid [HA], Botulinum Toxin Type A, Calcium Hydroxylapatite [CaHA], Polymer Fillers); Application (Wrinkle Reduction, Facelift, Acne Scar Treatment, Lipoatrophy Treatment, Lip Enhancement); End-user (Hospitals, Specialty Clinics, Dermatology & Beauty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4442
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Facial Injectables Landscape

top-features-companies
    • Ipsen Pharma
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merz Pharma
    • Suneva Medical, Inc.
    • Medytox
    • Sinclair Pharma
    • Bloomage BioTechnology Corporation Limited
    • Anika Therapeutics Inc.
    • Prollenium Medical Technologies
    • Galderma
    • AbbVie Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • To improve the hydration, elasticity, and firmness of the skin as well as the appearance of fine lines, Merz Pharma, a world authority in medical aesthetics, has introduced Belotero Revive, a dermal filler product. It contains a special blend of hyaluronic acid (HA) and glycerol.

  • Ipsen Pharma announced that it will invest in a brand-new, cutting-edge electronic autoinjector for Somatuline Autogel/Somatuline Depot (lanreotide), bringing the category even further into the future and enhancing patient administration and injection experiences

     


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4442
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are the growing income level of the population, the growing geriatric population, the increasing proportion of the male populace, and others.

The market is anticipated to attain a CAGR of ~10% over the forecast period, i.e., 2023-2033.

Side effects associated with dermal injectables, high cost attributed to these procedures, and lack of reimbursement policies are some of the major factors expected to hinder the growth of the market.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Ipsen Pharma, Merz Pharma, Suneva Medical, Inc., Medytox, Sinclair Pharma, Bloomage BioTechnology Corporation Limited, Anika Therapeutics Inc., Prollenium Medical Technologies, Galderma, AbbVie Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end-user, and by region.

The lip enhancement segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying